Jennifer L. Brown

Pfizer
Senior Director, Global Regulatory Affairs, CMC
Jennifer L. Brown is a Senior Director in the CMC group within Global Regulatory Sciences at Pfizer Inc in Groton, Connecticut. She and her team are responsible for CMC strategy for a global portfolio of investigational and commercial small molecule products. At Pfizer, Brown is currently a co-chair of the Excipient Council and is a member of the China Regulatory Network and Early Development Portfolio Management Group, and externally she chairs the ISPE Asia-Pacific Regional Focus Group and is secretary of the AAPS Regulatory Science Community. Brown received a B.S. in Chemistry from Muhlenberg College in Allentown, Pennsylvania, and an M.S. in Regulatory Affairs/Quality Assurance from Temple University. She started at Pfizer in Analytical R&D and has worked in Regulatory CMC for the past 25 years or so. Prior to joining Pfizer, she was a Peace Corps volunteer in Gabon, Central Africa, teaching middle school science, and Jen also served as a Pfizer Global Health Fellow, working at the Kakuma Refugee Camp in northern Kenya for several months in 2005. She is the current chair of the ISPE RQHC Asia-Pacific Regional Focus Group.

Related Articles

Asia Pacific Region Map - Image by Freepik
iSpeak Blog
ISPE Regulatory Volunteers Highlight Regulatory Challenges and Reform in Asia-Pacific

ISPE’s Regulatory Quality Harmonization Committee (RQHC) is structured with four Regional Focus Groups (RFGs): Asia-Pacific, Europe/Middle East/Africa, Latin America, and North America. The RFGs support ISPE in its understanding and response to regulatory issues and concerns for the specific region. The RQHC Asia-Pacific RFG includes pharmaceutical professionals located in or having specific...

A Proposal for a Comprehensive Quality Overall Summary
Features
A Proposal for a Comprehensive Quality Overall Summary

When working with the common technical dossier (CTD), the structure of Module 2 “follows the scope and outline of the Body of Data in Module 3,”1

  • 1International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. “Concept Paper: M4Q(R2) Common Technical Document on Quality Guideline.” Published 15 November 2021.
Is a Globally Harmonized Quality Overall Summary Possible?
Features
Is a Globally Harmonized Quality Overall Summary Possible?

The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guideline on Registration of Pharmaceuticals for Human Use (M4)1

  • 1International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. “The Common Technical Document for the Registration of Pharmaceuticals for Human Use: Quality–M4Q (R1)...